FDA Reprimands Snake Venom Seller For Pain Claims Amid Opioid Crisis

摘要

Nutra Pharma Corp. is exploiting the US opioid crisis with false claims that its cobra venom-containing Nyloxin ho- meopathic drug products can treat pain and heroin addic- tion, FDA says. The agency published a warning letter to the Coral Springs, Fla., frm on May 19, the same day it announced that the warning re- fects its homeopathic enforcement approach proposed in 2017.